Sunday 02 July 2017
11:45 - 13:00
Industry sponsored symposium
maandag 03 juli 2017
11:45 - 13:00: Industry sponsored symposium:
Personalising ovarian stimulation: Challenging the status quo
Jan-Steffen Krüssel, Germany
Laura Francesca Rienzi, Italy
Jan-Steffen Krüssel, Germany
Laura Francesca Rienzi, Italy
Pushing the envelope: Risks and rewards of high oocyte yield
Scott Nelson, United Kingdom
Personalisation in our hands: How far can we go today?
Christophe Blockeel, Belgium
Putting individualisation into practice: Experience with follitropin delta
Jan-Steffen Krüssel, Germany
Laura Francesca Rienzi, Italy
13:00 - 14:00
Industry sponsored session
13:00 - 14:00: Industry sponsored session:
14:00 - 15:15
Industry sponsored symposium
14:00 - 15:15: Industry sponsored symposium:
Natural diversity in ART outcome
Dominique De Ziegler, France
Claus Andersen Yding, Denmark
14:00 - 14:05
Welcome and introduction
14:05 - 14:25
Precision medicine: assess FSH and LH receptor polymorphism
Yvonne L. Lundberg Giwercman, Sweden
14:25 - 14:45
Ethnical diversity in COS responses and implantation rates
14:45 - 15:05
Empowering COS: matching expectations and yields
15:05 - 15:15
Conclusions
16:00 - 17:00
Industry sponsored session
16:00 - 17:00: Industry sponsored session:
Insulin sensitizers and PCOS: Physiology and therapeutic use of inositols
17:00 - 18:15
Industry sponsored symposium
17:00 - 18:15: Industry sponsored symposium:
Transforming fertility management
Marc Germond, Switzerland
Bart C.J.M. Fauser, The Netherlands
Marc Germond, Switzerland
17:05 - 17:21
Fibroids and fertility: From present to future
17:22 - 17:38
Safeguarding fertility: Why the debate?
17:39 - 17:55
Preventing transmission of abnormal mitochondrial DNA
Alison Murdoch, United Kingdom
17:55 - 18:00
Closing Remarks
Bart C.J.M. Fauser, The Netherlands
11:45 - 13:00
Industry sponsored symposium
dinsdag 04 juli 2017
11:45 - 13:00: Industry sponsored symposium:
Reducing time to live birth by optimizing ovarian response and embryo assessment
11:50 - 11:55
Introduction: Impact of female age and treatment discontinuation on time to live birth
Christian De Geyter, Switzerland
11:55 - 12:15
Optimizing ovarian response with personalized rFSH starting dose selection and flexible dose adaptation
Human Mousavi Fatemi, United Arab Emirates
12:15 - 12:35
Recombinant LH supplementation during ovarian stimulation: impact on oocyte quality and live birth
12:35 - 12:55
Improving reproductive outcomes with continuous embryo assessment
Geoffrey David Adamson, U.S.A.
12:55 - 13:00
Summary and closing remarks
Christian De Geyter, Switzerland
13:00 - 14:00
Industry sponsored session
13:00 - 14:00: Industry sponsored session:
Securing improved workflow efficiency in practice
David K. Gardner, Australia
Quality and workflow efficiency - two sides of the same coin
Using efficiencies from time-lapse technology to reduce the cost of IVF
Cristina Hickman, United Kingdom
Time-efficient vitrification will support workflow optimisation
14:00 - 15:15
Industry sponsored symposium
14:00 - 15:15: Industry sponsored symposium:
Re-evaluating success in ART: Useful measures in optimizing patient outcomes
14:00 - 14:05
Chairman’s welcome and opening remarks
14:05 - 14:20
Defining success in ART
14:20 - 14:45
Preimplantation genetic diagnosis for aneuploidy (PGD-A) in the clinical setting
14:45 - 15:10
Ovarian stimulation and cumulative live birth rates
Nikolaos P. Polyzos, Spain
15:10 - 15:15
Closing remarks
16:30 - 17:30
Industry sponsored session
16:30 - 17:30: Industry sponsored session:
New solutions for high throughput analysis of mosaicism and translocations in preimplantation samples
16:30 - 17:00
Unbalanced products of reciprocal translocation detection using Ion PGM™ System and Ion Reporter™ Software
Sebastian Pukszta, Poland
17:00 - 17:30
High throughput analysis of preimplantation and mosaic samples: pilot experiment results using the Ion ReproSeq™ PGS Kits for the Ion S5™ System
Fabien Murisier, Switzerland
Marta Cotado, Switzerland